Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLISS: Short vs Long Course Prednisolone for IESS
NCT06838559Phase 4Active, not recruiting
- Sponsor
- University of Colombo
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of prednisolone in infantile epileptic spasms syndrome (IESS) (2 arms), sponsored by University of Colombo. Primary endpoint: Electroclinical Remission at Day 14 and Day 28. Started Jan 2025; status: active, not recruiting.
02
Drugs
prednisolone
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT06838559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06838559.